Back

Baseline serum sodium as a non-negligible factor predicting increased risk of 3-month mortality in patients with light-chain amyloidosis diagnosed in cardiology department

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Jakub Malinowski

National Institute of Cardiology, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Okuno (Kumamoto, JP)
Abstract
Presentation thumbnail
Doctor M. Vidak (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
Doctor G. Aleshcheva (Berlin, DE)
Abstract Slides
Presentation thumbnail
Doctor P. Savage (Belfast, GB)
Abstract Slides

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis and biomarkers of heart failure

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging
thumbnail
Congress Presentation
Echocardiographic parameters as predictors of prognosis in cardiac amyloidosis: a systematic review and meta-analysis
thumbnail
Congress Presentation
Improving survival rates of patients with light-chain cardiac amyloidosis in recent years

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources